Ownership history in UBS Group AG · 21 quarters on record
This page tracks every 13F SEC filing in which UBS Group AG reported a position in ARCADIA BIOSCIENCES INC (RKDA). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | REDUCED | 565 | -534 | -48.6% | 0.00% | $1K | $1.98 |
| 2025 Q3 | REDUCED | 1,099 | -1,445 | -56.8% | 0.00% | $4K | $3.47 |
| 2025 Q2 | REDUCED | 2,544 | -6,016 | -70.3% | 0.00% | $11K | $4.31 |
| 2025 Q1 | REDUCED | 8,560 | -5,385 | -38.6% | 0.00% | $25K | $2.97 |
| 2024 Q4 | ADDED | 13,945 | +13,706 | +5734.7% | 0.00% | $83K | $5.92 |
| 2024 Q3 | ADDED | 239 | +237 | +11850.0% | 0.00% | $652 | $2.73 |
| 2024 Q1 | REDUCED | 2 | -5,008 | -100.0% | 0.00% | $4 | $2.21 |
| 2023 Q2 | ADDED | 5,010 | +1,801 | +56.1% | 0.00% | $19K | $3.88 |
| 2023 Q1 | REDUCED | 3,209 | -12,466 | -79.5% | 0.00% | $24K | $7.47 |
| 2022 Q3 | ADDED | 15,675 | +11,114 | +243.7% | 0.00% | $8K | $21.12 |
As of 2025 Q4 — sorted by position size